Sharp Edge Labs: Discovering Drugs to Treat Genetic Disorders of Protein Trafficking.

Sharp Edge Labs
Sharp Edge LabsThursday, January 26th, 2017 at 5:50am
Sharp Edge Labs and Cell Guidance Make New Technology Available to Study Exosomes (Important in Cancer Cell Communications)
4    View on Facebook
Sharp Edge Labs
Sharp Edge LabsWednesday, January 11th, 2017 at 3:46am
Outsourcing Pharma asks us about our collaboration with Sumitomo and we talk a bit about what precision medicine will mean for patients and payers in the future.
3    View on Facebook
Sharp Edge Labs
Sharp Edge LabsWednesday, January 4th, 2017 at 5:05am
Big News for us! We've just anounced a new discovery collaboration in neurodegeneration.
23 7    View on Facebook
Sharp Edge Labs
Sharp Edge LabsWednesday, December 28th, 2016 at 7:39am
We're at it again! Sharp Edge Labs is hiring BS/MS-level biologists to join our Drug Discovery Group. You'll do great work, and work on discovering next generation drugs that make a real difference for patients.
If you are a cell-biologist, molecular biologist, or assay development scientist please apply at
We look forward to learning about you, and telling you about us!
1 1    View on Facebook
Sharp Edge Labs
Sharp Edge LabsFriday, September 9th, 2016 at 4:30am
Here's a fun thing! Bill Newlin, our founding investor, and a champion of Sharp Edge Labs from the very beginning to today, did a radio interview on Pittsburgh Tech Council's TechVibe Radio where he discusses Sharp Edge, and another local tech company, LiquidX. Truly essential to have people like Bill in our community. You can listen here.
3 1    View on Facebook
Off the Shelf
  • Monogenic Diseases
    Caused by a single gene alteration, monogenic diseases represent an area of high unmet need, and also of great therapeutic opportunity.
  • Trafficking Defects
    Many monogenic diseases result from a mutation that causes improper trafficking, the failure of the mutated protein to get to the right place inside the cell.
  • Patient-Driven Discovery
    Stem-Cell technology allows patients to participate in drug discovery programs at their earliest stages.
On the Bench
Sharp Edge Radar